Liver Injury Following Isoniazid Preventive Therapy in HIV Patients Attending Halibet National Referral Hospital, Eritrea: A Prospective Cohort Study

INTRODUCTION: A 6-month course of isoniazid, 300 mg daily, was programmatically introduced in Eritrea in 2014 as tuberculosis preventive therapy in people living with human immunodeficiency virus (PLHIV). The rollout of isoniazid preventive therapy (IPT) in PLHIV was successful in the first 2–3 year...

Descripción completa

Detalles Bibliográficos
Autores principales: Russom, Mulugeta, Jeannetot, Daniel Y. B., Berhane, Araia, Woldu, Henok G., Stricker, Bruno H., Verhamme, Katia M. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248330/
https://www.ncbi.nlm.nih.gov/pubmed/37289412
http://dx.doi.org/10.1007/s40801-023-00375-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248330/
https://www.ncbi.nlm.nih.gov/pubmed/37289412
http://dx.doi.org/10.1007/s40801-023-00375-1

Ejemplares similares